The GRIBOI association stands for “Groupe de Recherche Interdisciplinaire sur les Biomatériaux Ostéoarticulaires Injectables”, and was first founded and led by Dr. Hervé Deramond, pioneer and founder of vertebroplasty.

For many years the GRIBOI association, under M. Bohner’ s successful presidency, has been bringing together the Basic Sciences in Chemistry, Bioengineering and Biocompatibility, in collaboration with Medical Doctors from Interventional Radiology, Neurosurgeons and Orthopedics, allowing us as a group to step into the future of new biocompatible devices and materials for percutaneous interventions.

Our 2017 meeting, in partnership with the “Hellenic Society of Nanotechnology in Health Sciences”, aims upon three major pillars: Interdisciplinary Collaboration, Image Guided Therapy and Injectable Materials.

This year’s meeting, taking place in Athens, Greece from 18-21 May 2017, will offer unparalleled opportunities for networking with colleagues and luminaries from around the globe. Consultants and young scientists together with industry in a common ground on Percutaneous Image Guided Therapies, will have the chance to explore a new world with ground breaking science.

On behalf of the GRIBOI organization, volunteers and staff, we wish you an extraordinary, memorable and productive stay here in Athens, Greece.


The Presidents of the 27th GRIBOI Meeting
A. D. Kelekis MD, PhD
Ass. Prof. of Interv. Radiology
University of Athens
President of the GRIBOI Society
P. J. Papagelopoulos MD, PhD
Professor & Chairman
First Department of Orthopedics
Athens University Medical School
& Attikon University General Hospital,
Athens Greece
E. P. Efstathopoulos PhD
Prof. of Medical Physics
University of Athens
President of the Greek Society of Nanotechnology


Athens, 18-21 May 2017
Divani Apollon Palace & Thalasso
10, Ag. Nikolaou & Iliou Str.
166 71 Vouliagmeni
T: 0030 210 8911100


Important Dates:

Early Bird Registration Deadline: 31 March 2017
New Abstract Submission Deadline: 06 March 2017


*Notice about Abstracts:
All accepted and presented abstracts will be published at eCM Journal (Eur Cell Mater). eCM Journal Impact Factor: 4.560, 5-Year Impact Factor: 5.680
For samples of previous publications please follow this link



Abstract Submission Deadline Extended
Please note that the deadline for submission has been extended for an extra 20 days, until March 6th, 2017.


Please download, fill and send us by email the registration forms

Registration Form Accommodation Form

Online Registration Online Accommodation